# EDGAR Filing Document

**Accession Number:** 0001849380
**File Stem:** 0001641172-25-018840
**Filing Date:** 2025-7
**Character Count:** 3730
**Document Hash:** 661d8484b7cc756772d1ca807830231f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-018840.hdr.sgml**: 20250909

**ACCESSION NUMBER**: 0001641172-25-018840

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250711

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OneMedNet Corp
- **CENTRAL INDEX KEY:** 0001849380
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 862076743
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** TRIDENT COURT, 1 OAKCROFT ROAD
- **STREET 2:** CHESSINGTON
- **CITY:** SURREY
- **STATE:** X0
- **ZIP:** KT9 1BD
- **BUSINESS PHONE:** 011-44-208-090-2009

**MAIL ADDRESS:**
- **STREET 1:** TRIDENT COURT, 1 OAKCROFT ROAD
- **STREET 2:** CHESSINGTON
- **CITY:** SURREY
- **STATE:** X0
- **ZIP:** KT9 1BD

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Data Knights Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210304

![](formcorresp_001.jpg)

July 11, 2025

**<u>VIA EDGAR</u>**

Division of Corporation Finance

Office of Industrial Applications and Services

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attention: Kat Bagley and Robert Augustin

---

| | |
|:---|:---|
| **Re:** | **OneMedNet Corporation** |
|  | **Amendment No. 4 to Registration Statement on Form S-1** |
|  | **Filed June 25, 2025** |
|  | **File No. 333-276130** |

---

Dear Ms. Bagley and Mr. Augustin:

In response to your oral comment delivered by telephone to the Company's counsel on July 8, 2025 (the "Oral Comment"), OneMedNet Corporation (the "Company") hereby submits this response to the Oral Comment relating to the above-referenced Registration Statement on Form S-1 (the "Registration Statement"). For convenience, the Oral Comment is set forth herein, followed by our response. The Company has revised the Registration Statement in response to the Staff's comment and is filing concurrently with this letter an Amendment No. 5 to the Registration Statement (the "Amendment") that reflects these revisions and generally updates other information contained therein.

<u>Amendment No. 4 to Registration Statement on Form S-1</u>

<u>General</u>

1. We
 note your revised disclosure that you are registering for resale "250,000 shares of
 Common Stock to be issued to Slickage Studios LLC ("Slickage") pursuant to a
 letter agreement to settle certain debts owed by the Company to Slickage." Please revise
 the disclosure where appropriate to provide the material terms of the letter agreement between
 the Company and Slickage, and file the letter agreement or tell us why you are not required
 to do so. See Section 601(b)(10) of Regulation S-K.

**Response:** We respectfully acknowledge the Staff's comment, and the Amendment has been updated to provide the material terms of the letter agreement between the Company and Slickage. The letter agreement between the Company and Slickage has also been filed with the Amendment.

\* \* \* \*

Division of Corporation Finance

Office of Industrial Applications and Services

July 11, 2025

If we can facilitate the Staff's review, or if the Staff has any questions on any of the information set forth herein, please telephone me at 800-918-7189. Thank you again for your time and consideration.

---

| | |
|:---|:---|
| Respectfully submitted, | Respectfully submitted, |
| By: | */s/ Aaron Green* |
|  | Aaron Green |
|  | Chief Executive Officer |

---

cc: Robert Golden, Chief Financial Officer (OneMedNet Corporation) <br> Eitan Hoenig, Perkins Coie LLP <br> Ned Prusse, Perkins Coie LLP